From January 1, 2022 to March 13, 2022, the company has repurchased 860,800 shares, representing 0.14% for CNY 9.03 million. With this, the company has completed the repurchase of 5,000,000 shares, representing 0.81% for CNY 59.98 million under the buyback announced on March 15, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.21 CNY | -0.71% |
|
-4.10% | -34.22% |
24/06 | Wanbangde Pharmaceutical Holding Group Co., Ltd.(XSEC:002082) dropped from S&P Global BMI Index | CI |
20/05 | Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-34.22% | 35Cr | |
+20.70% | 4.38TCr | |
+30.16% | 2.28TCr | |
+18.68% | 1.43TCr | |
+54.86% | 1.3TCr | |
-0.05% | 678.76Cr | |
-11.72% | 641.27Cr | |
-8.87% | 572.55Cr | |
+14.65% | 568.66Cr | |
+9.49% | 475.06Cr |
- Stock Market
- Equities
- 002082 Stock
- News Wanbangde Pharmaceutical Holding Group Co., Ltd.
- Tranche Update on Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback Plan announced on March 15, 2021.